FERAGALLI, Beatrice
 Distribuzione geografica
Continente #
NA - Nord America 5.433
AS - Asia 4.023
EU - Europa 3.366
SA - Sud America 669
OC - Oceania 56
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 13.610
Nazione #
US - Stati Uniti d'America 5.321
SG - Singapore 1.713
CN - Cina 949
IE - Irlanda 563
IT - Italia 554
BR - Brasile 547
RU - Federazione Russa 415
UA - Ucraina 396
VN - Vietnam 373
SE - Svezia 366
TR - Turchia 340
GB - Regno Unito 282
DE - Germania 227
FR - Francia 183
IN - India 164
HK - Hong Kong 138
FI - Finlandia 70
ES - Italia 58
AU - Australia 53
CA - Canada 51
AR - Argentina 48
JP - Giappone 42
AT - Austria 41
NL - Olanda 39
PL - Polonia 37
ID - Indonesia 36
BD - Bangladesh 34
BE - Belgio 34
MX - Messico 34
TW - Taiwan 29
TH - Thailandia 27
EC - Ecuador 26
IR - Iran 26
IQ - Iraq 25
PT - Portogallo 25
KR - Corea 23
MY - Malesia 23
ZA - Sudafrica 21
CZ - Repubblica Ceca 15
PK - Pakistan 15
CO - Colombia 13
CH - Svizzera 12
CL - Cile 10
RO - Romania 10
PY - Paraguay 9
EU - Europa 7
JO - Giordania 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
IL - Israele 6
LT - Lituania 6
MA - Marocco 6
PA - Panama 6
PH - Filippine 6
VE - Venezuela 6
HR - Croazia 5
JM - Giamaica 5
NI - Nicaragua 5
SA - Arabia Saudita 5
UY - Uruguay 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 4
EG - Egitto 4
BO - Bolivia 3
GR - Grecia 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AO - Angola 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
KW - Kuwait 2
ME - Montenegro 2
MM - Myanmar 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
SC - Seychelles 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 13.600
Città #
Singapore 1.211
Chandler 659
Jacksonville 577
Dublin 547
San Jose 493
Ashburn 343
Princeton 254
Dallas 244
Beijing 220
Santa Clara 175
Izmir 166
Nanjing 165
Ho Chi Minh City 142
Los Angeles 138
Southend 127
Hong Kong 118
Wilmington 117
Altamura 104
The Dalles 103
New York 97
Hanoi 92
Cambridge 83
Ann Arbor 74
Dearborn 67
Nanchang 60
Chieti 56
Redondo Beach 49
Boardman 48
Orem 41
Moscow 40
São Paulo 40
Tongling 37
Buffalo 35
Kunming 33
Milan 33
Munich 33
Tokyo 33
Catania 31
Shenyang 31
Frankfurt am Main 30
Hebei 29
Seattle 28
Chennai 26
Menlo Park 26
Tianjin 25
Falls Church 24
Denver 23
Brussels 22
Sydney 22
Woodbridge 22
Houston 21
Jiaxing 21
Rio de Janeiro 21
Amsterdam 20
Warsaw 20
Washington 20
London 19
Santa Pola 19
Vienna 19
Boston 18
Brooklyn 18
Da Nang 18
Istanbul 18
Hangzhou 17
Kuala Lumpur 17
Norwalk 17
Atlanta 16
Manchester 16
Toronto 16
Mumbai 15
Shanghai 15
Taichung 15
Changsha 14
Curitiba 14
Helsinki 14
Johannesburg 14
Pescara 14
Rome 14
Chicago 13
Council Bluffs 13
Haiphong 13
Montreal 13
Nuremberg 13
Phoenix 13
Stoke-on-Trent 13
Calpe 12
Guangzhou 12
Taipei 12
Lanzhou 11
Poplar 11
Pune 11
Stockholm 11
Ankara 10
Bangkok 10
Columbus 10
Bengaluru 9
Guayaquil 9
Jakarta 9
Melbourne 9
Mexico City 9
Totale 7.919
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 458
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections 208
Cone beam computed tomography for dental and maxillofacial imaging: technique improvement and low-dose protocols 207
Effects of different doses of Pycnogenol® on plasma oxidative stress: A pilot, supplement study 201
Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study 191
[Possibility of false negative results in the diagnosis of lung neoplasms with computerized tomography] 183
Pulmonary nodule [Il nodulo polmonare] 172
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 163
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 157
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 155
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 152
Biomechanical aspects in late implant failures: Scanning electron microscopy analysis of four clinical cases 151
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 147
Mononucleosis-related fatigue: supplementary management with Robuvit®. 142
Moderate, diffuse, somatic muscular pain: Effects of supplementation with a Pycnogenol patch 139
Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events 137
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 137
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 134
Supplementation with a new food grade delivery system of Boswellia and Centella in the intervertebral discs registry: The Sager study 134
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 133
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 131
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 130
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 129
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 129
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 129
Management of symptoms, pain and mobility with supplementary managements (including Movardol Forte) in osteoarthrosis: A 6-month, morphology supplement study 129
Anatomical features of cephalothoracopagus variations: CT and MRI. 128
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol (R) 128
Valutazione dell'area valvolare aortica (AVA): confronto fra risonanza cardiaca (RCM), ecocardiografiatranstoracia (ETT) e transesofagea (ETE) 127
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 127
Assessment of aortic valve area (AVA) by cardiac magnetic resonance (CMR) imaging in comparison with transthoracic (TTE) and transesophageal echocardiography (TEE) 126
Exploring the concept of vigor and dys-vigor in men of 50-65 years: effects of Robuvit® 126
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 126
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 125
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 124
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 123
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 120
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 120
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 119
Ecografia toracica. Diagnosi e tecniche interventistiche 119
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 118
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 117
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 117
Malignant pleural disease 117
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum® 117
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 117
Robuvit®: improvement of fatigue in medical convalescence. 116
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 113
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 113
7T mMR in the assessment of acute arterial mesenteric ischemia in a rat model 112
Chronic venous insufficiency and venous microangiopathy: Management with compression and Pycnogenol® 112
Improvement of common cold with Pycnogenol®: a Winter registry study. 111
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 110
Primary benign back pain: supplementation with Pycnogenol® 110
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 108
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 108
Errors in imaging of traumatic injuries 108
Small-Bowel Neoplasms: Role of MRI Enteroclysis 108
Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. 107
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 107
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 107
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 106
Pycnogenol® supplementation in minimal cognitive dysfunction 106
Non-small cell lung carcinoma. Early diagnosis: applicability of a screening 105
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 105
Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization 105
Radiographic evaluation of mediastinal lines as a diagnostic approach to occult or subtle mediastinal abnormalities. 104
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 104
Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress 104
Central Cardiovascular Calcifications: Supplementation With Pycnogenol® and Centellicum®: Variations Over 12 Months 104
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study. 100
A sport cream (Harpago-Boswellia-ginger-escin) for localized neck/shoulder pain 100
Malignant pleural disease 99
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 99
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 99
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 99
Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry 98
Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study 98
Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study 98
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 97
Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide 97
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. 96
Pycnogenol® prevents oxidative stress and side effects in patients with hypothyroidism during levothyroxine treatment 96
Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. 95
Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: Use and limitations 95
Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. 92
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 92
Thoracic ultrasound in children: evidence and drawbacks 91
Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing 91
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 90
Pleural disease 90
Ocular and optic nerve ischemia: recognition and treatment with intravenous prostaglandin E1. 89
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 89
Pulmonary nodule. 88
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study 88
Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol® 87
Pycnogenol® improvements in asthma management. 86
Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study. 85
Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study 85
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 84
Totale 12.105
Categoria #
all - tutte 52.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 0 0 0 0 0 0 37 28 30
2021/2022664 25 19 10 102 75 38 20 49 37 22 73 194
2022/20231.889 182 272 93 201 165 360 116 155 210 25 74 36
2023/20241.020 57 40 75 34 58 227 252 54 43 58 34 88
2024/20252.625 164 535 420 76 102 103 47 142 358 139 216 323
2025/20264.522 329 181 571 742 460 294 714 348 525 358 0 0
Totale 14.179